|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-9-4
|
|
pubmed:abstractText |
beta 1-integrin modulates cellular phenotype by mediating signals from the extracellular matrix (ECM). Although overexpression of integrin molecules in hepatocellular carcinoma (HCC) has been reported, the role of overexpressed beta 1-integrin in the disease process of HCC is not fully understood. The authors investigated the effects of beta 1-integrin on apoptosis in hepatoma cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10751
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
896-906
|
|
pubmed:dateRevised |
2006-4-13
|
|
pubmed:meshHeading |
pubmed-meshheading:12209735-Antigens, CD29,
pubmed-meshheading:12209735-Antineoplastic Agents,
pubmed-meshheading:12209735-Apoptosis,
pubmed-meshheading:12209735-Carcinoma, Hepatocellular,
pubmed-meshheading:12209735-Cell Division,
pubmed-meshheading:12209735-Humans,
pubmed-meshheading:12209735-Liver Neoplasms,
pubmed-meshheading:12209735-MAP Kinase Signaling System,
pubmed-meshheading:12209735-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12209735-Signal Transduction,
pubmed-meshheading:12209735-Transfection,
pubmed-meshheading:12209735-Tumor Cells, Cultured
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
|
|
pubmed:affiliation |
Division of Hepatology and Metabolism, Department of Internal Medicine, Saga Medical School, Saga, Japan.
|
|
pubmed:publicationType |
Journal Article
|
